Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Insomnia Treatments: New Perspectives"
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Clinical Neurology".
Deadline for manuscript submissions: closed (15 February 2023) | Viewed by 1689
Special Issue Editor
Interests: sleep medicine; sleep duration; sleep epidemiology; narcolepsy; central nervous system hypersomnia
Special Issue Information
Sleep disorders are among the most common medical complaints worldwide, affecting approximately 30% of the general population. Insomnia is the most common sleep disorder and the clinical diagnostic criteria defining insomnia disorder include not only sleep disruption but also consequent daytime impairment. Insomnia can also have devastating effects on human health, including a higher risk of obesity, cardiovascular disease, diabetes, alcohol abuse, and incident and recurrent depression.
The identification of a person’s specific insomnia symptoms can help guide treatments. While cognitive behavioral therapy for insomnia (CBT-I) is considered first-line treatment, not all patients respond to or have access to CBT-I. Pharmacological treatments include several different drug classes, such as benzodiazepines; non-BZD hypnotic “Z-drugs,” such as zolpidem or eszopiclone; dual orexin receptor antagonists; melatonin receptor agonists; histamine antagonists; and classes, such as sedating antidepressants.
Insomnia management is complex and changed significantly in the past decade. Several new pharmacologic treatments have been introduced, expanding the scope of options for therapy. Y the availability of newer pharmacologic therapies and optimal treatments for specific insomnia outcomes is not well-defined, and there is a dire need for improved education on treatment options and patient-physician dialogue.
Submissions of original research articles on the clinical management of insomnia are welcomed for this Special Issue. In particular, reviews focusing on the latest pharmacologic treatment options are encouraged.
Prof. Dr. Nathaniel Watson
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- insomnia medications
- drug therapy
- daytime function
- sleep disorders